During the first month of the year 2013, Mirna Technologies Incorporated released a statement saying that they had a new member on their Board of Directors. Their new member of the Board of Directors for Mirna Technologies Inc goes by the name of Dr. Clay Siegall. Dr. Clay Siegall is a very well known name is the science world. This is because of the fact that he is the co-founder of Seattle Genetics, the Chairman of the Board of Directors for Seattle Genetics, and also the Chief Executive Officier, which is most commonly referred to as the CEO, of the company Seattle Genetics. Dr. Clay Siegall and his team at Seattle Genetics have been making huge advancements in their cancer treatment research ever since they opened in the year of 1998. In addition to the cancer research, the company has also created and perfected a type of antibody treatment that can be used to aid in the treatment of various diseases such as cancer. With all of these advancements coming from Dr. Clay Siegall and his team at the company Seattle Genetics, it can be easily assumed that the Mirna Technologies Incorporated team was very excited work with a man coming from such a successful company. Dr. Clay Siegall confirmed his excitement during the press release statement from Mirna Technologies Incorporated whenever they were annoucing the fact that they had a new member on their Board of Directors.
Dr. Clay Siegall started his marketing career after he obtained his college degree. He obtained his Bachelor of Science degree in Zoology from the University of Maryland. From here, he went on to The George Washington University to obtain his Doctor of Philosophy in Genetics. After graduating, Clay Siegall began his job life much of which included Seattle Genetics and Mirna Technologies Incorporated. In addition to serving on the Board of Directors at Mirna Technologies Incorporated, working as the Chief Executive Officier, or CEO, at Seattle Genetics, and serving as the Chairman of the Board of Directors at Seattle Genetics, Dr. Clay Siegall has done a number of different things career wise. He currently works on the Board of Directors for Alder Biopharmaceuticals Incorporated and Ultragenyx Pharmaceutical. He is holding all of these positions at one time and has for quite a few years. This shows that he is truly dedicated to the science/medical field and is putting his heart and soul into the well being of humans around the world.